Compound class
GLP-1 receptor peptide analogs
Designed peptide analogs whose declared molecular relationship is agonism at the glucagon-like peptide-1 receptor.
01
Neutral class definition
Designed peptide analogs whose declared molecular relationship is agonism at the glucagon-like peptide-1 receptor.
02
Related compounds
Compound
Exenatide
Exenatide is a 39-residue peptide with an N-terminal histidine and a C-terminal serine amide, originally isolated from Heloderma suspectum venom and characterized as a member of the glucagon superfamily.
Exendin-4
Compound
Liraglutide
Liraglutide is an acylated peptide analog of glucagon-like peptide-1, characterized against the GLP-1 receptor.
NN2211
Compound
Semaglutide
Semaglutide is an acylated peptide analog of glucagon-like peptide-1. Its discovery record identifies two amino-acid substitutions and derivatization at Lys26.
NN9535 · NNC 0113-0217
03
Related molecular mechanisms
04
Relevant glossary terms
05
Verified bibliography
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.current
Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T
Journal of medicinal chemistry · 2015-09-11 · Journal Article
- Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes.current
Zhang X, Belousoff MJ, Liang YL, Danev R, Sexton PM, Wootten D
Cell reports · 2021-07-13 · Journal Article
- The Discovery and Development of Liraglutide and Semaglutide.current
Knudsen LB, Lau J
Frontiers in endocrinology · 2019-04-12 · Review
06
Related Purely Peptides research articles
07